A safe, T cell-inducing heterologous vaccine against elephant endotheliotropic herpesvirus in a proof-of-concept study

Abstract We report the results of the world’s first trial of a vaccine against elephant endotheliotropic herpesvirus (EEHV) in elephants. EEHV-induced haemorrhagic disease is a major threat to juvenile Asian elephants. A vaccine preventing severe disease and death would support conservation efforts...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Tanja Maehr, Javier Lopez, Gabby Drake, Frederico M. Ferreira, Richard Fraser, Rebecca Mckown, Reshma Kailath, Susan Morris, Adam Chambers, Leo P. Graves, Susan L. Walker, Akbar Dastjerdi, Katie L. Edwards, Helder I. Nakaya, Falko Steinbach
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Nature Portfolio 2025-10-01
Schriftenreihe:	Nature Communications
Online-Zugang:	https://doi.org/10.1038/s41467-025-64004-x
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!